TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Prepaid Expense
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Prepaid Expense of $2.60 million for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2021-05-13
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for the quarter ending 2021-03-31 was -$189.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for the quarter ending 2020-12-31 was $2.81M.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for the quarter ending 2020-09-30 was -$24.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for the quarter ending 2020-06-30 was $240.33K, a 498.18% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for fiscal 2020 was $75.33K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for fiscal 2019 was -$754.68K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for fiscal 2018 was -$173.19K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense for fiscal 2016 was -$100.91K, a 1069.23% decline from fiscal 2015.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $2.62M derived: sum of 2 quarters · filed 2021-05-13 | $2.60M 10-Q · filed 2021-05-13 | $2.84M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-12-31 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | $2.79M 10-Q · filed 2021-02-12 | $3.03M derived: sum of 3 quarters · filed 2021-02-12 | $3.02M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-09-30 | -$24.00K 10-Q · filed 2020-11-12 | $216.33K derived: sum of 2 quarters · filed 2020-11-12 | $207.33K derived: sum of 3 quarters · filed 2021-05-13 | $107.33K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-06-30 | $240.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $231.33K derived: sum of 2 quarters · filed 2021-05-13 | $131.33K derived: sum of 3 quarters · filed 2021-05-13 | $75.33K 10-K · filed 2020-09-18 | |||
| 2020-03-31 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | -$109.00K derived: sum of 2 quarters · filed 2021-05-13 | -$165.00K 10-Q · filed 2021-05-13 | -$165.38K 10-Q · filed 2020-05-13 | -$124.82K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | -$156.00K 10-Q · filed 2021-02-12 | -$157.25K 10-Q · filed 2020-02-13 | -$115.82K derived: sum of 3 quarters · filed 2021-02-12 | -$182.41K derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-09-30 | -$56.00K 10-Q · filed 2020-11-12 | -$56.53K 10-Q · filed 2019-11-13 | -$15.82K derived: sum of 2 quarters · filed 2020-11-12 | -$82.41K derived: sum of 3 quarters · filed 2020-11-12 | -$607.22K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $40.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -$26.41K derived: sum of 2 quarters · filed 2020-09-18 | -$551.22K derived: sum of 3 quarters · filed 2020-09-18 | -$754.68K 10-K · filed 2020-09-18 | |||
| 2019-03-31 | -$66.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$591.40K derived: sum of 2 quarters · filed 2020-05-13 | -$794.86K 10-Q · filed 2020-05-13 | -$832.76K derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$524.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | -$728.28K 10-Q · filed 2020-02-13 | -$766.17K derived: sum of 3 quarters · filed 2020-02-13 | -$834.15K derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-09-30 | -$203.46K 10-Q · filed 2019-11-13 | -$241.36K derived: sum of 2 quarters · filed 2019-11-13 | -$309.33K derived: sum of 3 quarters · filed 2019-11-13 | -$385.02K derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | -$37.90K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | -$105.87K derived: sum of 2 quarters · filed 2019-09-09 | -$181.56K derived: sum of 3 quarters · filed 2019-09-09 | -$173.19K 10-K · filed 2019-09-09 | |||
| 2018-03-31 | -$67.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$143.66K derived: sum of 2 quarters · filed 2019-05-14 | -$135.29K 10-Q · filed 2019-05-14 | $953.05K derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-12-31 | -$75.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$67.32K 10-Q · filed 2019-02-11 | $1.02M derived: sum of 3 quarters · filed 2019-06-03 | $1.01M derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-09-30 | $8.37K 10-Q · filed 2018-11-13 | $1.10M derived: sum of 2 quarters · filed 2019-06-03 | $1.09M derived: sum of 3 quarters · filed 2019-06-03 | $1.04M derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-06-30 | $1.09M derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $1.08M derived: sum of 2 quarters · filed 2019-06-03 | $1.03M derived: sum of 3 quarters · filed 2019-06-03 | $1.06M 8-K · filed 2019-06-03 | |||
| 2017-03-31 | -$11.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | -$57.56K derived: sum of 2 quarters · filed 2018-05-15 | -$24.36K 10-Q · filed 2018-05-15 | $34.48K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$46.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$13.34K 10-Q · filed 2018-02-14 | $45.50K derived: sum of 3 quarters · filed 2018-02-14 | -$36.71K derived: sum of 4 quarters · filed 2018-02-14 | |||
| 2016-09-30 | $33.21K 10-Q · filed 2017-11-09 | $92.05K derived: sum of 2 quarters · filed 2017-11-09 | $9.84K derived: sum of 3 quarters · filed 2017-11-09 | -$4.31K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $58.84K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | -$23.37K derived: sum of 2 quarters · filed 2017-09-27 | -$37.52K derived: sum of 3 quarters · filed 2017-09-27 | -$100.91K 10-K · filed 2017-09-27 | |||
| 2016-03-31 | -$82.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | -$96.36K derived: sum of 2 quarters · filed 2017-05-12 | -$159.75K 10-Q · filed 2017-05-12 | -$163.71K derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | -$14.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$77.54K 10-Q · filed 2017-02-10 | -$81.50K derived: sum of 3 quarters · filed 2017-02-10 | $11.64K derived: sum of 4 quarters · filed 2017-02-10 | |||
| 2015-09-30 | -$63.38K 10-Q · filed 2016-11-10 | -$67.35K derived: sum of 2 quarters · filed 2016-11-10 | $25.80K derived: sum of 3 quarters · filed 2016-11-10 | $19.41K derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | -$3.96K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $89.18K derived: sum of 2 quarters · filed 2016-09-13 | $82.79K derived: sum of 3 quarters · filed 2016-09-13 | $10.41K 10-K · filed 2016-09-13 | |||
| 2015-03-31 | $93.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | $86.76K derived: sum of 2 quarters · filed 2016-05-12 | $14.38K 10-Q · filed 2016-05-12 | -$20.58K derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | -$6.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | -$78.77K 10-Q · filed 2016-02-12 | -$113.73K derived: sum of 3 quarters · filed 2016-02-12 | -$15.03K derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-09-30 | -$72.38K 10-Q · filed 2015-11-16 | -$107.34K derived: sum of 2 quarters · filed 2015-11-16 | -$8.64K derived: sum of 3 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | -$34.96K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | $63.74K derived: sum of 2 quarters · filed 2015-11-16 | $13.37K 10-K · filed 2015-11-16 | ||||
| 2014-03-31 | $98.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $48.32K 10-Q · filed 2015-05-15 | |||||
| 2013-12-31 | -$50.38K 10-Q · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |